Abstract
Traditionally the role of nuclear magnetic resonance (NMR) in drug discovery has been as an analytical tool to aid chemists in characterizing small molecule compounds and identifying novel natural products (see Chapter 5). Today, due to the development and massive application of x-ray crystallography and NMR to determine atomic-resolution structures of proteins, nucleic acids, and their complexes, NMR has established itself as a key method in structure based drug design [1] (see also Chapter 8). Unfortunately, structure-based drug design by NMR becomes more difficult with increasing molecular weight of the target. Thus, although rational drug design has proven to be effective for several targets, there has been a major shift to high throughput screening (HTS) of large libraries of compounds. HTS methods only require a sufficiently robust assay which, when miniaturized, is used to screen hundreds of thousands of small molecule compounds.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Roberts GCK (1999) NMR spectroscopy in structure-based drug design. Curr Opin Biotech 10: 42–47
Moore JM (1999) NMR screening in drug discovery. Curr Opin Biotech 10: 54–58
Roberts GCK (2000) Applications of NMR in drug discovery. Drug Discovery Today 5: 230–240
Feeney J, Birdsall B (1993) NMR studies of protein-ligand interactions. In: Roberts GCK (ed): NMR of macromolecules. Oxford University Press, Oxford, 183–215
Jardetzki O, Roberts GCK (1981) NMR in molecular biology. Academic Press, San Diego
Craig DJ, Higgins KA (1998) NMR studies of ligand-macromolecule interactions. Annu Rep NMR Spectrosc 22: 61–138
Shuker SB, Hajduk PJ, Meadows RP et al (1996) Discovering high-affinity ligands for proteins: SAR by NMR. Science 274: 1531–1534
Hajduk PJ, Sheppard G, Nettesheim DG et al (1997) Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR. JAm Chem Soc 119: 5818–5827
Hajduk PJ, Dinges J, Miknis GF et al (1997) NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. J Med Chem 40: 3144–3150
Hajduk PJ, Dinges J, Schkeryantz JM et al (1999) Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis. J Med Chem 42: 3852–5859
Sattler M, Schleucher J, Griesinger C (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog NMR Spectrosc 34: 93–158
Rizo J, Liu ZP, Gierasch LM (1994) 1H and 15N resonance assignments and secondary structure of cellular retinoic acid-binding protein with and without bound ligand. J Biomol NMR 4: 741–760
Hensmann M, Booker GW, Panayotou G et al (1994) Phosphopeptide binding to the N-terminal SH2 domain of the p85. subunit of PI 3’-kinase: A heteronuclear NMR study. Protein Science 3: 1020–1030
Dalvit C, Floersheim P, Zurini M et al (1999) Use of organic solvents and small molecules for locating binding sites on proteins in solutions. J Biomol NMR 14: 23–32
Pervushin K, Riek R, Wider G et al (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci USA 23: 12366–12371
Pellecchia M, Sebbel P, Hermanns U et al (1999) Pilus chaperone FimC-adhesin FimH interactions mapped by TROSY-NMR. Nat Struct Biol 4: 336–339
Hajduk PJ, Gerfin T, Boehlen JM et al (1999) High-throughput nuclear magnetic resonance-based screening. J Med Chem 42: 2315–2317
Lian LY, Roberts GCK (1993) Effects of chemical exchange on NMR spectra. In: GCK Roberts (ed): NMR of macromolecules. Oxford University Press, Oxford, 153–182
van de Ven FJM (1995) Multidimensional NMR in liquids. VCH, Weinheim
Limmer S, Vogtherr M, Nawrot B et al (1997) Specific recognition of a minimal model of aminoacylated tRNA by the elongation factor Tu of bacterial protein biosynthesis. Angew Chem Int Ed Engl 36: 2485–2489
Scherf T, Anglister J (1993) A T1 rho-filtered two-dimensional transferred NOE spectrum for studying antibody interactions with peptide antigens. Biophys J 64: 754–761
Hajduk PJ, Olejniczak ET, Fesik SW (1997) One-dimensional relaxation-and diffusion-edited NMR methods for screening compounds that bind to macromolecules. JAm Chem Soc 119: 12257–12261
Ni F (1994) Recent developments in transferred NOE methods. Prog NMR Spectrosc 26: 517–606
Meyer B, Weimar T, Peters T (1997) Screening mixtures for biological activity by NMR. Eur J Biochem 246: 705–709
Henrichsen D, Ernst B, Magnani JL et al (1999) Bioaffinity NMR spectroscopy: Identification of an E-selectin antagonist in a substance mixture by transfer NOE. Angew Chem Int Ed Engl 38: 98–102
Herfurth L, Weimar T, Peters T (2000) Application of 3D TOCSY-TrNOESY for the assignment of bioactive ligands from mixtures. Angew Chem Int Ed Engl 39; 2097–2099
Breeze AL (2000) Isotope-filtered NMR methods for the study of biomolecular structure and interactions. Prog NMR Spectrosc 36: 323: 372
Stejskal EO, Tanner JE (1965) Spin diffusion measurement: Spin echoes in the presence of a time-dependent field gradient. J Chem Phys 42: 288–292
Lin M, Shapiro MJ (1996) Mixture analysis in combinatorial chemistry. Application of diffusion-resolved NMR spectroscopy. J Org Chem 61: 7617–7619
Lin M, Shapiro MJ, Wareing JR (1997) Screening mixtures by affinity NMR. J Org Chem 62: 8930–8931
Lin M, Shapiro MJ, Wareing JR (1997) Diffusion-edited NMR—affinity NMR for direct observation of molecular interactions. JAm Chem Soc 119: 5249–5350
Anderson RC, Lin M, Shapiro MJ (1999) Affinity NMR: Decoding DNA binding. J Comb Chem 1:69–72
Bleicher K, Lin M, Shapiro MJ et al (1998) Diffusion edited NMR: Screening compound mixtures by affinity NMR to detect binding ligands to vancomycin. J Org Chem 63: 8486–8490
Mayer M, Meyer B (1999) Characterization of ligand binding by saturation transfer difference NMR spectra. Angew Chem Int Ed Engl 35: 1784–1788
Klein J, Meinecke R, Mayer M et al (1999) Detecting binding affinity to immobilized receptor proteins in compound libraries by HR-MAS STD NMR. JAm Chem Soc 121: 5336–5337
Chen A, Shapiro MJ (1998) NOE pumping: A novel NMR technique for identification of compounds with binding affinity to macromolecules. JAm Chem Soc 120: 10258–10259
Shapiro MJ, Chen A (2000) NOE pumping. 2. A high-throughput method to determine compounds with binding affinity to macromolecules by NMR. JAm Chem Soc 122: 414–415
Vogtherr M, Peters T (2000) Application of NMR based binding assays to identify key hydroxy groups for intermolecular recognition. JAm Chem Soc 122: 6093–6099
Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39: 2887–2893
Bemis GW, Murcko MA (1999) Properties of known drugs. 2. Side chains. J Med Chem 42: 5095–5099
Fejzo J, Lepre CA, Peng JW et al (1999) The SHAPES strategy: An NMR-based approach for lead generation in drug discovery. Chem Biol 6: 755–769
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Basel AG
About this chapter
Cite this chapter
Vogtherr, M., Fiebig, K. (2003). NMR-based screening methods for lead discovery. In: Hillisch, A., Hilgenfeld, R. (eds) Modern Methods of Drug Discovery. EXS, vol 93. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7997-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7997-2_9
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9397-8
Online ISBN: 978-3-0348-7997-2
eBook Packages: Springer Book Archive